Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking

Biol Psychiatry. 2007 Sep 15;62(6):694-7. doi: 10.1016/j.biopsych.2006.11.018. Epub 2007 Mar 6.

Abstract

Background: The purpose of this study was to examine the interactive effects of family history of alcoholism (FH+, FH-) and naltrexone dose (0, 50, 100 mg/day) on alcohol drinking.

Methods: Ninety-two, non-treatment-seeking alcohol-dependent participants received naltrexone daily for 6 days. On the 6th day, they participated in a laboratory paradigm involving exposure to a priming dose of alcohol followed by a 2-hour drinking period in which they made choices between consuming alcoholic drinks and receiving money.

Results: Total number of drinks consumed during the drinking period was significantly decreased by the 100-mg dose of naltrexone in FH+ drinkers. Secondary analyses in male drinkers (n = 70) indicated that 100 mg of naltrexone significantly decreased drinking in FH+ participants and increased drinking in FH- drinkers.

Conclusions: These results suggest that family history of alcoholism might be a significant clinical predictor of response to naltrexone and that FH+ men are more likely to benefit from naltrexone therapy for alcohol drinking.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / prevention & control*
  • Alcohol Drinking / psychology
  • Alcoholism / drug therapy*
  • Alcoholism / genetics*
  • Alcoholism / psychology
  • Behavior, Addictive / genetics
  • Behavior, Addictive / prevention & control
  • Behavior, Addictive / psychology
  • Choice Behavior / drug effects
  • Dose-Response Relationship, Drug
  • Family / psychology*
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Naltrexone / administration & dosage
  • Naltrexone / pharmacology
  • Naltrexone / therapeutic use*
  • Narcotic Antagonists / administration & dosage
  • Narcotic Antagonists / pharmacology
  • Narcotic Antagonists / therapeutic use*
  • Reward
  • Sex Factors
  • Treatment Outcome

Substances

  • Narcotic Antagonists
  • Naltrexone